A Brief Introduction to Epidemiology - XI (Epidemiologic Research ...

Reviews
Shared by: IBDa Joker
Stats
views:
7
rating:
not rated
reviews:
0
posted:
1/23/2009
language:
UNKNOWN
pages:
0
A Brief Introduction to Epidemiology - XI (Epidemiologic Research Designs: Experimental/Interventional Studies) Betty C. Jung, RN, MPH, CHES BC Jung Learning Objectives To understand: – What experimental studies are – The value of such studies – The basic methodology – Pros and Cons of such studies BC Jung Introduction The primary purpose of research is to conduct a scientific, or, scholarly investigation into a phenomenon, or to answer a burning question. Research is defined as a systematic approach to problem solving. BC Jung Epidemiological Study Designs Studies - examine associations between risk factors and outcomes (Analytical - determinants and risk of disease, and descriptive - patterns and frequency of disease)  Intervention Studies - explore the association between interventions and outcomes. (Experimental studies or clinical trials) BC Jung  Observational Epidemiological Study Designs  Observational – Cross-Sectional – Case-control – Cohort Interventional – Natural Experiment (Community Trial) – Field Trial – Experiment/Randomized Trails (ex. Clinical Trial) BC Jung Examples of Experimental Epidemiologic Studies vaccines tested on children populations to prove the efficacy of the vaccines in preventing the diseases (i.e., polio)  Prophylaxis with drugs in preventing disease (i.e., penicillin to prevent rheumatic fever)  Impact on health-related behavior and coronary heart disease in response to community-wide heart disease prevention intervention BC Jung  Prophylactic Value are seen as the “Supreme Court” of epidemiologic research as they provide the strongest possible evidence of disease causation.  Experimental study designs can rule out with greater certainty factors that may confound potential cause and affect relationships.  A study’s degree of internal validity depends on the study design’s ability to determine whether an antecedent causes an effect (or outcome). BC Jung  Experiments Community Trials rather than individuals comprise the treatment groups Appropriate for diseases that have their origins in social conditions that can be influenced by intervention directed at group behavior as well as individuals Communities BC Jung Limitations of Community Trials Random allocation of communities is not practical Only a small number of communities can be included Other methods are needed to ensure any difference found can be attributed to the intervention rather than to any inherent differences between the communities studied BC Jung Field Trials people who are disease-free but presumed to be at risk Data collection – “in the field” – among non-institutionalized people in the general population Used to evaluate interventions that reduce exposure without measuring the occurrence of health effects. BC Jung Involve Limitations of Field Trials undertaking Major logistic considerations Major financial considerations Think of how much work is required to randomize and allocate participants to various treatment groups! BC Jung Hugh Experimental Study Design Time Treated (T) Sample of Cases Treated - Improved Treated – Not Improved Not Treated - Improved Not Treated (NT) (Control) Not Treated – Not Improved BC Jung Randomized Trial Methodology allocation - Each subject has an equal chance of being assigned to any group in the study, so that all groups in a study are similar in all characteristics not controlled by other methods, such as subject selection.  Random allocation can be used with matching to ensure the study groups are comparable BC Jung  Random Randomized Trial Design Time R A N Defined D Population O M I Z E D New Treatment Improved Not Improved Improved Not Improved Current Treatment BC Jung Four Possibilities treatments do not differ and we correctly conclude they do not differ The treatments do not differ but we conclude they do differ The treatments differ but we conclude they do not differ The treatments do differ and we correctly conclude that they do differ BC Jung The Pros in assessing the value of new therapies to combat acute diseases in developing countries  Can evaluate a single variable in a precisely defined patient group  Prospective design  Eliminates bias by comparing two otherwise identical groups  Allows for meta-analysis BC Jung  Helpful Cons and time consuming  Not always properly conducted – too few subjects, too short a time period  Influence of sponsorship  Use of surrogate endpoints may introduce “hidden bias”  Failure to randomize all eligible subjects  Failure to blind assessors to randomized status of subjects BC Jung  Expensive References For Internet Resources on the topics covered in this lecture, check out my Web site: http://www.bettycjung.net/ BC Jung

Related docs
premium docs
Other docs by IBDa Joker
Copyright Compliance Photocopying Policy
Views: 285  |  Downloads: 2
Studies in the Psychology of Sex
Views: 805  |  Downloads: 108
Manufacturers business plan
Views: 495  |  Downloads: 19
ADDRESS BOOK
Views: 490  |  Downloads: 14
DD Form 1707 Information to Offerors or Quoters
Views: 439  |  Downloads: 3
Personal Financial Statement
Views: 1013  |  Downloads: 39
Liberate Technologies Ammendments and Bylaws
Views: 139  |  Downloads: 0
Stock Subscription Agreement
Views: 985  |  Downloads: 51
Intermix Media Inc Ammendments and Bylaws
Views: 126  |  Downloads: 0